ArticleJAMA2012
Strategies to help a smoker who is struggling to quit.
Article in JAMA, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Evaluating the Effectiveness of Brief Interventions for Smoking Cessation Performed by Family Doctors.Medicina (Kaunas, Lithuania) · 2024Pooled it
- Smoking Cessation for Smokers Not Ready to Quit: Meta-analysis and Cost-effectiveness Analysis.American journal of preventive medicine · 2018Pooled it
- Group randomized trial of teaching tobacco-cessation counseling to senior medical students: a peer role-play module versus a standardized patient module.BMC medical education · 2019Trial
- Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial.American journal of preventive medicine · 2016Trial
- Design and initial enrollment in the Vascular Physicians Offer and Report (VAPOR) trial.Journal of vascular surgery · 2016Trial
- Trial
- Documented Tobacco Cessation Care and Patient Outcomes in Malawi: Analysis of Post-Training Clinical Records.Advances in medical education and practice · 2026Article
- Tobacco cessation: screening and interventions.Korean journal of family medicine · 2025Article
- Repeated participation in hospital smoking cessation services and its effectiveness in smoking cessation: a seven-year observational study in Taiwan.Archives of public health = Archives belges de sante publique · 2024Article
- Experiences of smoking and tobacco use during pregnancy: A qualitative study protocol.PloS one · 2024Article
- Article
- Immunotherapies for the Treatment of Drug Addiction.Vaccines · 2022Review
- Tobacco Use and Treatment of Tobacco Dependence Among People With Human Immunodeficiency Virus: A Practical Guide for Clinicians.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Article
- Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021Article
- Efficacy of an inpatient smoking cessation program at a single regional cancer center: A prospective observational study.Medicine · 2021Observational
- The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.BMC cancer · 2020Article
- A survey exploring knowledge and beliefs about electronic cigarettes between health care providers and the general population in Egypt.International journal of chronic obstructive pulmonary disease · 2019Article
- Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat.Frontiers in behavioral neuroscience · 2019Article
- Immunological and toxicological risk assessment of e-cigarettes.European respiratory review : an official journal of the European Respiratory Society · 2018Review
Corrections and comments
- Commented on by
Authors and funding
1 author.
Funding
Abstract
Tobacco use is the leading preventable cause of death worldwide. Stopping tobacco use benefits virtually every smoker. Most of the 19% of US residents who smoke want to quit and have tried to do so. Most individual quit attempts fail, but two-thirds of smokers use no treatment when trying to quit. Treating tobacco dependence is one of the most cost-effective actions in health care. With a brief intervention, physicians can prompt smokers to attempt to quit and connect them to evidence-based treatment that includes pharmacotherapy and behavioral support (ie, counseling). Physicians can link smokers to effective counseling support offered by a free national network of telephone quit lines. Smokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit double their odds of success. The most effective way to use NRT is to combine the long-acting nicotine patch with a shorter-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks. Observational studies have not confirmed case reports of behavior changes associated with varenicline and bupropion, and these drugs' benefits outweigh potential risks. A chronic disease management model is effective for treating tobacco dependence, which deserves as high a priority in health care systems as treating other chronic diseases like diabetes and hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.